These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Sidelmann JJ; Sjøland JA; Gram J; Bertelsen V; Mourits-Andersen T; Münster H; Münster AM; Jespersen J Scand J Clin Lab Invest; 2007; 67(3):270-9. PubMed ID: 17454841 [TBL] [Abstract][Full Text] [Related]
26. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies. Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611 [TBL] [Abstract][Full Text] [Related]
27. Expression of apoptosis in placenta of experimental antiphospholipid syndrome mouse. Velayuthaprabhu S; Matsubayashi H; Sugi T; Nakamura M; Ohnishi Y; Ogura T; Archunan G Am J Reprod Immunol; 2013 May; 69(5):486-94. PubMed ID: 23398188 [TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A; Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782 [TBL] [Abstract][Full Text] [Related]
29. Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Galli M; Comfurius P; Barbui T; Zwaal RF; Bevers EM Thromb Haemost; 1992 Sep; 68(3):297-300. PubMed ID: 1440495 [TBL] [Abstract][Full Text] [Related]
30. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889 [TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid syndrome: critical analysis of the diagnostic path. Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982 [TBL] [Abstract][Full Text] [Related]
32. Antiprothrombin antibody: why do we need more assays? Atsumi T; Koike T Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984 [TBL] [Abstract][Full Text] [Related]
33. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Kawakami T; Yamazaki M; Mizoguchi M; Soma Y Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170 [TBL] [Abstract][Full Text] [Related]
34. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies. Sahud M; Zhukov O; Mo K; Popov J; Dlott J Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845 [TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR; Cabiedes J; Alarcón-Segovia D Lupus; 2004; 13(3):182-7. PubMed ID: 15119547 [TBL] [Abstract][Full Text] [Related]
36. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C Lupus; 2007; 16(10):810-6. PubMed ID: 17895304 [TBL] [Abstract][Full Text] [Related]
38. [Lupus anticoagulants in patients with systemic lupus erythematosus]. Matsuura Y; Nawata Y; Miike S; Hiraguri M; Kita Y; Kurasawa K; Takabayashi K; Oh H; Iwamoto I; Saito Y Ryumachi; 1996 Feb; 36(1):16-24. PubMed ID: 8711533 [TBL] [Abstract][Full Text] [Related]
39. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays. Raby A; Moffat K; Crowther M Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus. Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]